Sexually Transmitted Diseases (STD) Testing Market Analysis and Forecast 2018-2025 | Roche Holdings AG, BioMerieux, Hologic, Becton Dickinson & Company, Cepheid, Danaher Corporation, Affymetrix, Alere

August 29 12:20 2019
Sexually Transmitted Diseases (STD) Testing Market Analysis and Forecast 2018-2025 | Roche Holdings AG, BioMerieux, Hologic, Becton Dickinson & Company, Cepheid, Danaher Corporation, Affymetrix, Alere

Sexually Transmitted Diseases (STD) Testing
Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), and Location of Testing (Laboratory Testing and POC Testing): Global Opportunity Analysis and Industry Forecast, 2018-2025

“Sexually Transmitted Diseases (STD) Testing Market by Disease Type and Location of Testing: Global Opportunity Analysis and Industry Forecast, 2018-2025,” the global STD testing market is expected to reach $133,935.7 million by 2025, registering a CAGR of 5.6% from 2018 to 2025.

Get Free Sample Copy of This [email protected] https://www.qurateresearch.com/report/sample/HnM/QBI-AMR-HnM-440312

At present, sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.The STD testing market has gained prominence in the recent years due to high prevalence of major sexually transmitted diseases worldwide and as a result, increase in need for STD diagnosis. However, limited access to STD diagnosis in majority of the population from developing regions is expected to restrain the market growth.

Based on disease type, the chlamydia segment is the highest revenue contributor and gonorrhea is expected to exhibit the fastest growth rate of 8.9%. This is attributed to the increased prevalence of gonorrhea in the last decade.

Asia-Pacific was the highest revenue contributor in the global STD testing market, accounting for 54.0% share in 2017. This region is also expected to grow at the highest rate, owing to the number of developing nations present in this region, rise in prevalence of sexually transmitted diseases, and increase in awareness.

Enquiry about [email protected] https://www.qurateresearch.com/report/enquiry/HnM/QBI-AMR-HnM-440312

Based on location of testing, the laboratory testing segment occupied the largest share of STD testing market in 2017. POC testing segment is expected to grow at the highest rate during the forecast period. Factors such as faster diagnosis with POC tests and expected rise in adoption of POCs in future, significantly contribute toward the growth of this segment.

The major companies profiled in this report include Roche Holdings AG, BioMerieux, Hologic Inc., Becton Dickinson & Company, Cepheid Inc., Danaher Corporation, Affymetrix, Alere Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., and DiaSorin

Purchase [email protected] https://www.qurateresearch.com/report/buy/HnM/QBI-AMR-HnM-440312/

Key Findings Of The Study

LAMEA occupied 40.0% share of the global STD testing market in 2017.
The Asia-Pacific segment is anticipated to grow with the highest CAGR throughout the forecast period.
The laboratory testing segment accounted for 85.0% share of the market in 2017. 
The POC testing segment is anticipated to grow at the highest rate during the analysis period.

Media Contact
Company Name: Qurate Business Intelligence
Contact Person: Nehal Chinoy
Email: Send Email
Phone: +919881074592
Address:Runwal Platinum, Ramnagar Colony, Bavdhan
City: Pune
State: Maharashtra
Country: India
Website: www.qurateresearch.com